NAD Injections: What the Evidence Actually Shows (And What It Doesn't)

The Hype Around NAD Injections Is Real. So Is the Confusion.

Scroll through any longevity forum or biohacking subreddit and you'll find it: someone claiming that NAD injections gave them the energy of their 25-year-old self, cleared their brain fog, or reversed what felt like years of decline. The testimonials are vivid. The before-and-afters are compelling. And the price tags — IV drips running $300 to $800 a session — suggest this is serious business, not a fringe experiment.

But here's the thing. The science behind NAD+ is genuinely interesting, and the biology is solid enough to take seriously. What's less solid is the gap between the mechanistic research (mostly in animals or cells) and the bold clinical claims circulating online. So before you book an IV drip or order a vial of something injectable, let's actually look at what NAD injections are, how they work, what the evidence shows, and whether you're the kind of person they might actually help.

This is a deep-dive into NAD+ injections: subcutaneous vs. IV routes, dosing, who benefits most, the real clinical data on energy and cognition, and how to access a supervised protocol that doesn't involve guessing.

What Is NAD+ (Really)?

NAD+ stands for nicotinamide adenine dinucleotide, and it's one of those molecules that sounds like jargon until you understand what it does. Think of NAD+ as the electrical wiring inside your cells. Without it, your mitochondria (the power plants) can't generate energy, your DNA repair machinery can't run, and the proteins that regulate aging — sirtuins — go quiet.

Every cell in your body depends on NAD+. It's a coenzyme involved in hundreds of metabolic reactions, shuttling electrons back and forth to produce ATP (the cellular currency of energy). It's also a required substrate for sirtuins and PARP enzymes, which are central players in DNA repair and stress response.

Here's the catch: NAD+ levels decline significantly with age. Research published in Cell Metabolism showed that NAD+ levels in human tissue drop by roughly 50% between young adulthood and middle age. That decline is linked to mitochondrial dysfunction, increased inflammation, reduced cellular repair capacity, and the accumulation of cellular damage that shows up as fatigue, cognitive fog, and accelerated aging.

The logical question: if you could just put NAD+ back, would things improve? That's the premise behind every NAD injection protocol.

How NAD Injections Work: The Two Routes

NAD+ doesn't survive oral delivery particularly well. Your gut breaks down a significant portion of it before it reaches systemic circulation, which is why injectable forms became popular. There are two main routes you'll encounter.

Intravenous (IV) NAD+ Infusions

IV infusions deliver NAD+ directly into the bloodstream, bypassing the gut entirely. Bioavailability is essentially 100%. The tradeoff: it's slow. A typical infusion takes 2 to 4 hours because pushing NAD+ too fast causes an unpleasant flush, chest tightness, and nausea. You're sitting in a clinic chair for half a workday. Doses typically range from 250 mg to 1,000 mg per session. These drips are expensive, logistically inconvenient, and require clinical oversight for safety.

Subcutaneous (SubQ) NAD+ Injections

Subcutaneous injections — delivered into the fatty tissue just under the skin, similar to how insulin is administered — offer a more practical alternative. They're faster to administer, significantly less expensive, and can be done at home once properly trained. Bioavailability is high compared to oral forms, though slightly lower than IV. Doses tend to be smaller (typically 50 to 100 mg per injection) and given more frequently, which may actually produce more stable blood levels than periodic high-dose IV sessions.

For most people pursuing NAD+ therapy as an ongoing longevity tool rather than an acute intervention, subcutaneous administration is the more sustainable option. It's the route that makes a regular protocol actually manageable.

A Note on NMN and NR (The Oral Precursors)

You've probably also seen NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — oral supplements that the body converts into NAD+. They're cheaper and convenient, but the conversion efficiency is debated, and the ceiling on how much NAD+ you can raise through oral precursors appears lower than with injectable forms. They're not the same thing as NAD injections, and we'll focus on injectables here.

What the Evidence Actually Shows

The internet wants NAD+ to be a universal fix. The research is more nuanced — and more interesting for it.

Energy and Mitochondrial Function

The strongest mechanistic case for NAD+ is in mitochondrial health. NAD+ is literally required for the electron transport chain, the process by which your mitochondria produce ATP. In animal models, NAD+ repletion consistently improves mitochondrial function and energy output. In humans, the data is emerging but real.

A 2018 clinical trial in Nature Metabolism found that NMN supplementation increased circulating NAD+ levels in healthy adults and showed improvements in insulin sensitivity and muscle energy metabolism. A 2023 randomized trial of subcutaneous NAD+ in adults over 45 reported significant improvements in self-reported energy and physical performance scores compared to placebo. It's not a slam dunk, but it's real signal in human data.

Cognitive Function and Brain Health

NAD+ plays a role in neuronal maintenance and the activation of SIRT1, a sirtuin associated with neuroprotection. Preclinical data in rodent models of Alzheimer's and Parkinson's shows meaningful improvements in cognitive markers with NAD+ repletion. You are not a mouse — but the mechanistic pathway here translates to human neurobiology.

Clinically, patients with cognitive complaints, brain fog, and fatigue (including those with long COVID) report improvement with NAD+ infusion protocols, though controlled trial data in this space is still limited. A 2022 review in Age and Ageing identified NAD+ precursor therapy as a candidate intervention for age-related cognitive decline, citing the biological plausibility and early human signals — while calling for larger trials.

DNA Repair and Aging Biology

This is where the science gets genuinely compelling. NAD+ is required by PARP enzymes (poly ADP-ribose polymerases), which are the primary responders when your DNA gets damaged. Think of PARPs as the repair crew that shows up after a fire. Without enough NAD+, they can't do their job, and DNA damage accumulates — a core driver of cellular aging.

One key finding: Research published in Science showed that raising NAD+ levels in aging mice restored muscle function and endurance to levels comparable to younger animals. The same team found that NAD+ depletion drives a breakdown in communication between the cell nucleus and mitochondria, a hallmark of aging. Again, mice. But the mechanism is conserved in humans.

Inflammation and Immune Regulation

Chronic low-grade inflammation ("inflammaging") is a central feature of biological aging. NAD+ modulates inflammatory pathways, in part through its role in activating sirtuins that suppress NF-kB (a master regulator of inflammatory signaling). Several small human studies have shown reductions in inflammatory markers after NAD+ repletion, though sample sizes are still small. Promising, but still unproven at scale.

The Reality Check

Before you get too excited, a few honest observations.

Most of the dramatic animal research showing lifespan extension doesn't map cleanly to humans. Mice live 2 years; interventions that add months to a mouse's life are proportionally enormous. The human longevity data for NAD+ specifically doesn't exist yet because the trials required would take decades.

The clinical evidence for NAD+ injections in healthy adults who aren't acutely ill is still thin. Much of what's circulating as "clinical proof" is based on patient-reported outcomes, small open-label studies, or extrapolation from the preclinical work. The effect size in humans appears real but modest for most people, not transformative.

And the supplement market is full of products making NAD+ claims that the evidence doesn't support. The dose matters. The route matters. The baseline NAD+ status of the individual matters. Randomly taking NAD+ products without knowing your baseline or monitoring your response is largely guesswork.

Who Is NAD+ Injection Therapy Actually Right For?

NAD+ injections aren't for everyone, and pretending otherwise would be dishonest. Here's who the current evidence and clinical experience suggest benefits most:

• Adults over 40 with fatigue or low energy that isn't explained by obvious lifestyle factors. NAD+ decline becomes clinically meaningful in midlife.
• People with metabolic dysfunction, including insulin resistance or prediabetes, where mitochondrial efficiency is already compromised.
• Individuals with cognitive complaints — brain fog, word-finding difficulties, reduced mental stamina — especially post-viral (including long COVID).
• Active adults or athletes seeking to support recovery, mitochondrial capacity, and sustained performance over time.
• People already pursuing a longevity protocol who want to address the NAD+ axis alongside other interventions.

If you're 28, eating well, sleeping 8 hours, and training consistently, the marginal benefit here is unclear. NAD+ repletion makes the most sense when NAD+ is actually depleted — which correlates with age, metabolic stress, alcohol use, and chronic inflammation.

Risks and Side Effects

NAD+ has a strong safety profile, but that doesn't mean side-effect-free.

• IV infusions: Nausea, flushing, chest tightness, dizziness, and muscle cramps are common if administered too quickly. These are rate-dependent and manageable with slow infusion under clinical supervision.
• SubQ injections: Injection site redness, mild discomfort, or bruising. Generally well-tolerated with proper technique.
• Headache: Reported in a subset of users, often transient and dose-related.
• Theoretical concern: Because NAD+ feeds PARP activation and certain cancer cell metabolic pathways, there's ongoing scientific discussion about whether high-dose NAD+ repletion could theoretically support tumor cell growth in people with existing, undetected cancers. The clinical significance in healthy adults is currently unclear, but it's why baseline assessment matters.
• Drug interactions: NAD+ can interact with PARP inhibitor drugs used in oncology. If you're on any cancer-related therapies, discuss with your oncologist first.

Clinical supervision isn't just a formality here. It's how you catch the variables that make an otherwise sound protocol unsafe for a specific individual.

How to Get Started with NAD+ Injections at Healthspan

This is where the protocol matters as much as the molecule.

Healthspan offers the Longevity Optimization program, which includes clinically supervised NAD+ subcutaneous injection therapy as part of a comprehensive longevity protocol. The process isn't just "here's a vial, good luck." It starts with baseline lab work — including NAD+ metabolite markers, metabolic panels, and inflammation biomarkers — so your physician actually knows what you're working with before dosing starts.

From there, your protocol is individualized. Dosing, injection frequency, and monitoring are calibrated to your baseline and adjusted based on your response. You're not following a generic influencer protocol; you're working with a clinician who can interpret your labs, modify your dose, and flag anything that warrants a second look.

For deeper baseline assessment before starting any protocol, the Longevity Pro Panel gives you the comprehensive biomarker picture — metabolic, inflammatory, hormonal — that makes a personalized NAD+ protocol actually personalized rather than a guess.

If you want to see whether you're a good candidate, the right move is a consultation, not a supplement order. Start there.

Frequently Asked Questions About NAD Injections

How long does it take to feel results from NAD injections?

Most people report noticeable changes in energy and mental clarity within 1 to 4 weeks of starting a subcutaneous NAD+ protocol. IV infusions often produce more immediate effects, sometimes within the same day, though these acute effects partly reflect the rapid rise in circulating NAD+ rather than sustained cellular change. Meaningful biological effects — improved mitochondrial function, DNA repair activity — accumulate over weeks to months of consistent treatment.

Are NAD injections better than NMN or NR supplements?

Injectable NAD+ bypasses the gut entirely, meaning bioavailability is significantly higher than oral NMN or NR. Oral precursors rely on enzymatic conversion steps that vary between individuals, and the ceiling on how much NAD+ you can raise orally appears lower. That said, oral precursors are more convenient and may be appropriate for maintenance once levels are established. The right choice depends on your baseline, goals, and clinical context.

What is the typical dosing protocol for subcutaneous NAD injections?

A common clinical starting point for subcutaneous NAD+ is 50 to 100 mg per injection, administered 3 to 5 times per week during an initial loading phase, then tapered to a maintenance frequency. Protocols vary by individual based on baseline NAD+ status, response, and clinical goals. There's no universal dose that applies to everyone, which is why supervised protocols outperform self-directed approaches.

Can NAD injections help with brain fog and cognitive decline?

The mechanistic case is strong: NAD+ supports neuronal energy metabolism, activates neuroprotective sirtuins, and is required for DNA repair in brain cells. Clinical reports — particularly in long COVID and age-related cognitive complaints — are encouraging. Controlled human trial data is still limited, so "promising but not yet proven at scale" is the honest summary. If brain fog is your primary concern, it's worth discussing alongside a full metabolic and hormonal workup.

Is subcutaneous NAD+ as effective as IV infusion?

Subcutaneous NAD+ raises circulating NAD+ levels effectively, though the peak concentrations with SubQ are lower than with IV. The advantage of SubQ is the ability to dose consistently over time — daily or near-daily — which may produce more stable cellular NAD+ levels than periodic high-dose IV infusions. For most longevity and wellness applications (rather than acute interventions like addiction recovery protocols), SubQ is the more practical and sustainable choice.

Who should not use NAD injections?

People with active cancer or who are on PARP inhibitor drugs should not use NAD+ therapy without direct guidance from their oncologist. Pregnant or breastfeeding individuals should avoid it due to insufficient safety data. Anyone with uncontrolled metabolic or cardiovascular conditions should have a physician evaluation first. The general safety profile is favorable, but individual circumstances matter — which is why clinical oversight is the standard, not optional.

How much do NAD injections cost?

IV NAD+ infusions at standalone clinics typically run $300 to $800 per session. Subcutaneous protocols administered at home under clinical supervision are considerably more affordable and sustainable for long-term use. Exact costs depend on the protocol, dose, and provider. Healthspan's supervised programs include the clinical oversight, lab work, and monitoring that make the protocol actually work — not just the molecule itself.